BioPlus Acquisition Corp (BIOS) insider trading

Every open-market stock purchase and sale by BioPlus Acquisition Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

No open-market insider trades in the last 12 months.
Last insider buy: Daniel E Greenleaf (CEO), $30.5K, 8 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent BIOS insider trades

No open-market trades in the last 12 months.

Get free alerts when an insider at BioPlus Acquisition Corp files a new trade →